{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Berberis thunbergii", "Chelidonium majus", "anticancer", "apoptosis", "berberine", "cytotoxicity", "leukemia", "sanguinarine"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "31443589", "DateCompleted": {"Year": "2020", "Month": "10", "Day": "20"}, "DateRevised": {"Year": "2023", "Month": "10", "Day": "14"}, "Article": {"ArticleDate": [{"Year": "2019", "Month": "08", "Day": "23"}], "Language": ["eng"], "ELocationID": ["485", "10.3390/toxins11090485"], "Journal": {"ISSN": "2072-6651", "JournalIssue": {"Volume": "11", "Issue": "9", "PubDate": {"Year": "2019", "Month": "Aug", "Day": "23"}}, "Title": "Toxins", "ISOAbbreviation": "Toxins (Basel)"}, "ArticleTitle": "Cytotoxic and Proapoptotic Activity of Sanguinarine, Berberine, and Extracts of <i>Chelidonium majus</i> L. and <i>Berberis thunbergii</i> DC. toward Hematopoietic Cancer Cell Lines.", "Abstract": {"AbstractText": ["Isoquinoline alkaloids belong to the toxic secondary metabolites occurring in plants of many families. The high biological activity makes these compounds promising agents for use in medicine, particularly as anticancer drugs. The aim of our study was to evaluate the cytotoxicity and proapoptotic activity of sanguinarine, berberine, and extracts of <i>Chelidonium majus</i> L. and <i>Berberis thunbergii</i> DC. IC10, IC50, and IC90 doses were established toward hematopoietic cancer cell lines using trypan blue staining. Alterations in the expression of 18 apoptosis-related genes in cells exposed to IC10, IC50, and IC90 were evaluated using real-time PCR. Sanguinarine and <i>Chelidonium majus</i> L. extract exhibit significant cytotoxicity against all studied cell lines. Lower cytotoxic activity was demonstrated for berberine. <i>Berberis thunbergii</i> DC. extract had no influence on cell viability. Berberine, sanguinarine, and <i>Chelidonium majus</i> L. extract altered the expression of apoptosis-related genes in all tested cell lines, indicating the induction of apoptosis. The presented study confirmed the substantial cytotoxicity and proapoptotic activity of sanguinarine, berberine, and <i>Chelidonium majus</i> L. extract toward the studied hematopoietic cell lines, which indicates the utility of these substances in anticancer therapy."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Chair and Department of Biology and Genetics, Medical University of Lublin, 4a Chod\u017aki St., 20-093 Lublin, Poland."}], "LastName": "Och", "ForeName": "Anna", "Initials": "A"}, {"Identifier": ["0000-0002-2254-2009"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Chair and Department of Biology and Genetics, Medical University of Lublin, 4a Chod\u017aki St., 20-093 Lublin, Poland."}], "LastName": "Zalewski", "ForeName": "Daniel", "Initials": "D"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Chair and Department of Medicinal Chemistry, Medical University of Lublin, 4 Jaczewskiego St., 20-090 Lublin, Poland."}], "LastName": "Komsta", "ForeName": "\u0141ukasz", "Initials": "\u0141"}, {"Identifier": ["0000-0002-3710-0860"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Chair and Department of Biology and Genetics, Medical University of Lublin, 4a Chod\u017aki St., 20-093 Lublin, Poland."}], "LastName": "Ko\u0142odziej", "ForeName": "Przemys\u0142aw", "Initials": "P"}, {"Identifier": ["0000-0002-9541-6353"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Clinical Genetics, Chair of Medical Genetics, Medical University of Lublin, 11 Radziwi\u0142\u0142owska St., 20-080 Lublin, Poland."}], "LastName": "Kocki", "ForeName": "Janusz", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Chair and Department of Biology and Genetics, Medical University of Lublin, 4a Chod\u017aki St., 20-093 Lublin, Poland. anna.kocka@umlub.pl."}], "LastName": "Bogucka-Kocka", "ForeName": "Anna", "Initials": "A"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Toxins (Basel)", "NlmUniqueID": "101530765", "ISSNLinking": "2072-6651"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents, Phytogenic"}, {"RegistryNumber": "0", "NameOfSubstance": "Benzophenanthridines"}, {"RegistryNumber": "0", "NameOfSubstance": "Isoquinolines"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}, {"RegistryNumber": "0I8Y3P32UF", "NameOfSubstance": "Berberine"}, {"RegistryNumber": "AV9VK043SS", "NameOfSubstance": "sanguinarine"}], "MeshHeadingList": [{"QualifierName": ["isolation & purification", "pharmacology"], "DescriptorName": "Antineoplastic Agents, Phytogenic"}, {"QualifierName": ["drug effects", "genetics"], "DescriptorName": "Apoptosis"}, {"QualifierName": ["isolation & purification", "pharmacology"], "DescriptorName": "Benzophenanthridines"}, {"QualifierName": ["isolation & purification", "pharmacology"], "DescriptorName": "Berberine"}, {"QualifierName": ["chemistry"], "DescriptorName": "Berberis"}, {"QualifierName": [], "DescriptorName": "Cell Line, Tumor"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Survival"}, {"QualifierName": ["chemistry"], "DescriptorName": "Chelidonium"}, {"QualifierName": ["drug effects"], "DescriptorName": "Gene Expression"}, {"QualifierName": [], "DescriptorName": "HL-60 Cells"}, {"QualifierName": ["drug effects", "pathology"], "DescriptorName": "Hematopoietic Stem Cells"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["isolation & purification", "pharmacology"], "DescriptorName": "Isoquinolines"}, {"QualifierName": ["isolation & purification", "pharmacology"], "DescriptorName": "Plant Extracts"}], "CoiStatement": "The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Trujillo-Villanueva K., Rubio-Pi\u00f1a J., Monforte-Gonz\u00e1lez M., Ram\u00edrez-Ben\u00edtez E., V\u00e1zquez-Flota F. The sequential exposure to jasmonate, salicylic acid and yeast extract promotes sanguinarine accumulation in Argemone mexicana cell cultures. Biotechnol. Lett. 2012;34:379\u2013385. doi: 10.1007/s10529-011-0770-x.", "ArticleIdList": ["10.1007/s10529-011-0770-x", "22009570"]}, {"Citation": "Cho H.Y., Rhee H.S., Yoon S.Y., Park J.M. Differential induction of protein expression and benzophenanthridine alkaloid accumulation in Eschscholtzia californica suspension cultures by methyl jasmonate and yeast extract. J. Microbiol. Biotechnol. 2008;18:255\u2013262.", "ArticleIdList": ["18309269"]}, {"Citation": "Obiang-Obounou B.W., Kang O.H., Choi J.G., Keum J.H., Kim S.B., Mun S.H., Shin D.W., Kim K.W., Park C.B., Kim Y.G., et al. The mechanism of action of sanguinarine against methicillin-resistant Staphylococcus aureus. J. Toxicol. Sci. 2011;36:277\u2013283. doi: 10.2131/jts.36.277.", "ArticleIdList": ["10.2131/jts.36.277", "21628956"]}, {"Citation": "Wang Q., Dai P., Bao H., Liang P., Wang W., Xing A., Sun J. Anti-inflammatory and neuroprotective effects of sanguinarine following cerebral ischemia in rats. Exp. Ther. Med. 2017;13:263\u2013268. doi: 10.3892/etm.2016.3947.", "ArticleIdList": ["10.3892/etm.2016.3947", "PMC5245136", "28123499"]}, {"Citation": "Ma Y., Sun X., Huang K., Shen S., Lin X., Xie Z., Wang J., Fan S., Ma J., Zhao X. Sanguinarine protects against osteoarthritis by suppressing the expression of catabolic proteases. Oncotarget. 2017;8:62900\u201362913. doi: 10.18632/oncotarget.17036.", "ArticleIdList": ["10.18632/oncotarget.17036", "PMC5609890", "28968958"]}, {"Citation": "Lee S.S., Kai M., Lee M.K. Inhibitory effects of sanguinarine on monoamine oxidase activity in mouse brain. Phytother. Res. 2001;15:167\u2013169. doi: 10.1002/ptr.703.", "ArticleIdList": ["10.1002/ptr.703", "11268121"]}, {"Citation": "Jursky F., Baliova M. Differential effect of the benzophenanthridine alkaloids sanguinarine and chelerythrine on glycine transporters. Neurochem. Int. 2011;58:641\u2013647. doi: 10.1016/j.neuint.2011.02.001.", "ArticleIdList": ["10.1016/j.neuint.2011.02.001", "21315125"]}, {"Citation": "Singh R., Mackraj I., Naidoo R., Gathiram P. Sanguinarine downregulates AT1a gene expression in a hypertensive rat model. J. Cardiovasc. Pharmacol. 2006;48:14\u201321. doi: 10.1097/01.fjc.0000238590.82438.64.", "ArticleIdList": ["10.1097/01.fjc.0000238590.82438.64", "16954816"]}, {"Citation": "Jeng J.H., Wu H.L., Lin B.R., Lan W.H., Chang H.H., Ho Y.S., Lee P.H., Wang Y.J., Wang J.S., Chen Y.J., et al. Antiplatelet effect of sanguinarine is correlated to calcium mobilization, thromboxane and cAMP production. Atherosclerosis. 2007;191:250\u2013258. doi: 10.1016/j.atherosclerosis.2006.05.023.", "ArticleIdList": ["10.1016/j.atherosclerosis.2006.05.023", "16797553"]}, {"Citation": "Kuznetsova L.P., Nikol\u2019skaya E.B., Sochilina E.E., Faddeeva M.D. Inhibition of Human Blood Acetylcholinesterase and Butyrylcholinesterase by Some Alkaloids. J. Evol. Biochem. Physiol. 2002;38:35\u201339. doi: 10.1023/A:1015561103682.", "ArticleIdList": ["10.1023/A:1015561103682", "11966199"]}, {"Citation": "Zajoncova L., Kosina P., Vicar J., Ulrichov\u00e1 J., Pec P. Study of the inhibition of alpha-amylase by the benzo[c]phenanthridine alkaloids sanguinarine and chelerythrine. J. Enzym. Inhib. Med. Chem. 2005;20:261\u2013267. doi: 10.1080/14756360500067504.", "ArticleIdList": ["10.1080/14756360500067504", "16119197"]}, {"Citation": "Imenshahidi M., Hosseinzadeh H. Berberine and barberry (Berberis vulgaris): A clinical review. Phytother. Res. 2019;33:504\u2013523. doi: 10.1002/ptr.6252.", "ArticleIdList": ["10.1002/ptr.6252", "30637820"]}, {"Citation": "Xu Y., Wang Y., Yan L., Liang R.M., Dai B.D., Tang R.J., Gao P.H., Jiang Y.Y. Proteomic analysis reveals a synergistic mechanism of fluconazole and berberine against fluconazole-resistant Candida albicans: Endogenous ROS augmentation. J. Proteome Res. 2009;8:5296\u20135304. doi: 10.1021/pr9005074.", "ArticleIdList": ["10.1021/pr9005074", "19754040"]}, {"Citation": "Li Z., Geng Y.N., Jiang J.D., Kong W.J. Antioxidant and anti-inflammatory activities of berberine in the treatment of diabetes mellitus. Evid. Based Complement. Altern. Med. 2014;2014:289264. doi: 10.1155/2014/289264.", "ArticleIdList": ["10.1155/2014/289264", "PMC3942282", "24669227"]}, {"Citation": "Chang W., Chen L., Hatch G.M. Berberine as a therapy for type 2 diabetes and its complications: From mechanism of action to clinical studies. Biochem. Cell Biol. 2015;93:479\u2013486. doi: 10.1139/bcb-2014-0107.", "ArticleIdList": ["10.1139/bcb-2014-0107", "25607236"]}, {"Citation": "Wang Y., Liu J., Ma A., Chen Y. Cardioprotective effect of berberine against myocardial ischemia/reperfusion injury via attenuating mitochondrial dysfunction and apoptosis. Int. J. Clin. Exp. Med. 2015;8:14513\u201314519.", "ArticleIdList": ["PMC4613127", "26550442"]}, {"Citation": "Fan J., Zhang K., Jin Y., Li B., Gao S., Zhu J., Cui R. Pharmacological effects of berberine on mood disorders. J. Cell Mol. Med. 2019;23:21\u201328. doi: 10.1111/jcmm.13930.", "ArticleIdList": ["10.1111/jcmm.13930", "PMC6307759", "30450823"]}, {"Citation": "Kongkiatpaiboon S., Duangdee N., Prateeptongkum S., Chaijaroenkul W. Acetylcholinesterase Inhibitory Activity of Alkaloids Isolated from Stephania venosa. Nat. Prod. Commun. 2016;11:1805\u20131806. doi: 10.1177/1934578X1601101208.", "ArticleIdList": ["10.1177/1934578X1601101208", "30508338"]}, {"Citation": "Galadari S., Rahman A., Pallichankandy S., Thayyullathil F. Molecular targets and anticancer potential of sanguinarine\u2014A benzophenanthridine alkaloid. Phytomedicine. 2017;34:143\u2013153. doi: 10.1016/j.phymed.2017.08.006.", "ArticleIdList": ["10.1016/j.phymed.2017.08.006", "28899497"]}, {"Citation": "Gaziano R., Moroni G., Bu\u00e8 C., Miele M.T., Sinibaldi-Vallebona P., Pica F. Antitumor effects of the benzophenanthridine alkaloid sanguinarine: Evidence and perspectives. World J. Gastrointest. Oncol. 2016;8:30\u201339. doi: 10.4251/wjgo.v8.i1.30.", "ArticleIdList": ["10.4251/wjgo.v8.i1.30", "PMC4714144", "26798435"]}, {"Citation": "Hussain A.R., Al-Jomah N.A., Siraj A.K., Manogaran P., Al-Hussein K., Abubaker J., Platanias L.C., Al-Kuraya K.S., Uddin S. Sanguinarine-dependent induction of apoptosis in primary effusion lymphoma cells. Cancer Res. 2007;67:3888\u20133897. doi: 10.1158/0008-5472.CAN-06-3764.", "ArticleIdList": ["10.1158/0008-5472.CAN-06-3764", "17440103"]}, {"Citation": "Weerasinghe P., Hallock S., Tang S.C., Liepins A. Role of Bcl-2 family proteins and caspase-3 in sanguinarine-induced bimodal cell death. Cell Biol. Toxicol. 2001;17:371\u2013381. doi: 10.1023/A:1013796432521.", "ArticleIdList": ["10.1023/A:1013796432521", "11787859"]}, {"Citation": "Weerasinghe P., Hallock S., Tang S.C., Liepins A. Sanguinarine induces bimodal cell death in K562 but not in high Bcl-2-expressing JM1 cells. Pathol. Res. Pract. 2001;197:717\u2013726. doi: 10.1078/0344-0338-00150.", "ArticleIdList": ["10.1078/0344-0338-00150", "11770015"]}, {"Citation": "Kim S., Lee T.J., Leem J., Choi K.S., Park J.W., Kwon T.K. Sanguinarine-induced apoptosis: Generation of ROS, down-regulation of Bcl-2, c-FLIP, and synergy with TRAIL. J. Cell Biochem. 2008;104:895\u2013907. doi: 10.1002/jcb.21672.", "ArticleIdList": ["10.1002/jcb.21672", "18189268"]}, {"Citation": "Park S.Y., Jin M.L., Kim Y.H., Lee S.J., Park G. Sanguinarine inhibits invasiveness and the MMP-9 and COX-2 expression in TPA-induced breast cancer cells by inducing HO-1 expression. Oncol. Rep. 2014;31:497\u2013504. doi: 10.3892/or.2013.2843.", "ArticleIdList": ["10.3892/or.2013.2843", "24220687"]}, {"Citation": "Basini G., Bussolati S., Santini S.E., Grasselli F. Sanguinarine inhibits VEGF-induced angiogenesis in a fibrin gel matrix. Biofactors. 2007;29:11\u201318. doi: 10.1002/biof.5520290102.", "ArticleIdList": ["10.1002/biof.5520290102", "17611290"]}, {"Citation": "Basini G., Santini S.E., Bussolati S., Grasselli F. Sanguinarine inhibits VEGF-induced Akt phosphorylation. Ann. N. Y. Acad. Sci. 2007;1095:371\u2013376. doi: 10.1196/annals.1397.040.", "ArticleIdList": ["10.1196/annals.1397.040", "17404049"]}, {"Citation": "Eun J.P., Koh G.Y. Suppression of angiogenesis by the plant alkaloid, sanguinarine. Biochem. Biophys. Res. Commun. 2004;317:618\u2013624. doi: 10.1016/j.bbrc.2004.03.077.", "ArticleIdList": ["10.1016/j.bbrc.2004.03.077", "15063803"]}, {"Citation": "Zou K., Li Z., Zhang Y., Zhang H.Y., Li B., Zhu W.L., Shi J.Y., Jia Q., Li Y.M. Advances in the study of berberine and its derivatives: A focus on anti-inflammatory and anti-tumor effects in the digestive system. Acta Pharmacol. Sin. 2017;38:157\u2013167. doi: 10.1038/aps.2016.125.", "ArticleIdList": ["10.1038/aps.2016.125", "PMC5309756", "27917872"]}, {"Citation": "Yan K., Zhang C., Feng J., Hou L., Yan L., Zhou Z., Liu Z., Liu C., Fan Y., Zheng B., et al. Induction of G1 cell cycle arrest and apoptosis by berberine in bladder cancer cells. Eur. J. Pharmacol. 2011;661:1\u20137. doi: 10.1016/j.ejphar.2011.04.021.", "ArticleIdList": ["10.1016/j.ejphar.2011.04.021", "21545798"]}, {"Citation": "Goto H., Kariya R., Shimamoto M., Kudo E., Taura M., Katano H., Okada S. Antitumor effect of berberine against primary effusion lymphoma via inhibition of NF-\u03baB pathway. Cancer Sci. 2012;103:775\u2013781. doi: 10.1111/j.1349-7006.2012.02212.x.", "ArticleIdList": ["10.1111/j.1349-7006.2012.02212.x", "PMC7659260", "22320346"]}, {"Citation": "Liu Z., Liu Q., Xu B., Wu J., Guo C., Zhu F., Yang Q., Gao G., Gong Y., Shao C. Berberine induces p53-dependent cell cycle arrest and apoptosis of human osteosarcoma cells by inflicting DNA damage. Mutat. Res. 2009;662:75\u201383. doi: 10.1016/j.mrfmmm.2008.12.009.", "ArticleIdList": ["10.1016/j.mrfmmm.2008.12.009", "19159633"]}, {"Citation": "Jin F., Xie T., Huang X., Zhao X. Berberine inhibits angiogenesis in glioblastoma xenografts by targeting the VEGFR2/ERK pathway. Pharm. Biol. 2018;56:665\u2013671. doi: 10.1080/13880209.2018.1548627.", "ArticleIdList": ["10.1080/13880209.2018.1548627", "PMC6319470", "31070539"]}, {"Citation": "Wang J., Kang M., Wen Q., Qin Y.T., Wei Z.X., Xiao J.J., Wang R.S. Berberine sensitizes nasopharyngeal carcinoma cells to radiation through inhibition of Sp1 and EMT. Oncol. Rep. 2017;37:2425\u20132432. doi: 10.3892/or.2017.5499.", "ArticleIdList": ["10.3892/or.2017.5499", "28350122"]}, {"Citation": "Liu Y., Yu H., Zhang C., Cheng Y., Hu L., Meng X., Zhao Y. Protective effects of berberine on radiation-induced lung injury via intercellular adhesion molecular-1 and transforming growth factor-beta-1 in patients with lung cancer. Eur. J. Cancer. 2008;44:2425\u20132432. doi: 10.1016/j.ejca.2008.07.040.", "ArticleIdList": ["10.1016/j.ejca.2008.07.040", "18789680"]}, {"Citation": "Singh N., Sharma B. Toxicological Effects of Berberine and Sanguinarine. Front. Mol. Biosci. 2018;5:21. doi: 10.3389/fmolb.2018.00021.", "ArticleIdList": ["10.3389/fmolb.2018.00021", "PMC5867333", "29616225"]}, {"Citation": "Das M., Ansari K.M., Dhawan A., Shukla Y., Khanna S.K. Correlation of DNA damage in epidemic dropsy patients to carcinogenic potential of argemone oil and isolated sanguinarine alkaloid in mice. Int. J. Cancer. 2005;117:709\u2013717. doi: 10.1002/ijc.21234.", "ArticleIdList": ["10.1002/ijc.21234", "15981203"]}, {"Citation": "Dixit R., Srivastava P., Basu S., Srivastava P., Mishra P.K., Shukla V.K. Association of mustard oil as cooking media with carcinoma of the gallbladder. J. Gastrointest. Cancer. 2013;44:177\u2013181. doi: 10.1007/s12029-012-9458-2.", "ArticleIdList": ["10.1007/s12029-012-9458-2", "23180022"]}, {"Citation": "Hossain M., Kabir A., Suresh Kumar G. Binding of the anticancer alkaloid sanguinarine with tRNA (phe): Spectroscopic and calorimetric studies. J. Biomol. Struct. Dyn. 2012;30:223\u2013234. doi: 10.1080/07391102.2012.677774.", "ArticleIdList": ["10.1080/07391102.2012.677774", "22702734"]}, {"Citation": "Adhami V.M., Aziz M.H., Mukhtar H., Ahmad N. Activation of prodeath Bcl-2 family proteins and mitochondrial apoptosis pathway by sanguinarine in immortalized human HaCaT keratinocytes. Clin. Cancer Res. 2003;9:3176\u20133182.", "ArticleIdList": ["12912970"]}, {"Citation": "Selvi B.R., Pradhan S.K., Shandilya J., Das C., Sailaja B.S., Shankar G.N., Gadad S.S., Reddy A., Dasgupta D., Kundu T.K. Sanguinarine interacts with chromatin, modulates epigenetic modifications, and transcription in the context of chromatin. Chem. Biol. 2009;16:203\u2013216. doi: 10.1016/j.chembiol.2008.12.006.", "ArticleIdList": ["10.1016/j.chembiol.2008.12.006", "19246011"]}, {"Citation": "Maiti M., Kumar G.S. Polymorphic nucleic Acid binding of bioactive isoquinoline alkaloids and their role in cancer. J. Nucleic Acids. 2010;2010:593408. doi: 10.4061/2010/593408.", "ArticleIdList": ["10.4061/2010/593408", "PMC2915887", "20814427"]}, {"Citation": "Ji X., Sun H., Zhou H., Xiang J., Tang Y., Zhao C. The interaction of telomeric DNA and C-myc22 G-quadruplex with 11 natural alkaloids. Nucleic Acid Ther. 2012;22:127\u2013136. doi: 10.1089/nat.2012.0342.", "ArticleIdList": ["10.1089/nat.2012.0342", "PMC3317788", "22480315"]}, {"Citation": "Choy C.S., Cheah K.P., Chiou H.Y., Li J.S., Liu Y.H., Yong S.F., Chiu W.T., Liao J.W., Hu C.M. Induction of hepatotoxicity by sanguinarine is associated with oxidation of protein thiols and disturbance of mitochondrial respiration. J. Appl. Toxicol. 2008;28:945\u2013956. doi: 10.1002/jat.1360.", "ArticleIdList": ["10.1002/jat.1360", "18548746"]}, {"Citation": "Ferraroni M., Bazzicalupi C., Bilia A.R., Gratteri P. X-Ray diffraction analyses of the natural isoquinoline alkaloids Berberine and Sanguinarine complexed with double helix DNA d(CGTACG) Chem. Commun. (Camb.) 2011;47:4917\u20134919. doi: 10.1039/c1cc10971e.", "ArticleIdList": ["10.1039/c1cc10971e", "21431128"]}, {"Citation": "Maiti M., Kumar G.S. Molecular aspects on the interaction of protoberberine, benzophenanthridine, and aristolochia group of alkaloids with nucleic acid structures and biological perspectives. Med. Res. Rev. 2007;27:649\u2013695. doi: 10.1002/med.20087.", "ArticleIdList": ["10.1002/med.20087", "16894530"]}, {"Citation": "Li X.L., Hu Y.J., Wang H., Yu B.Q., Yue H.L. Molecular spectroscopy evidence of berberine binding to DNA: Comparative binding and thermodynamic profile of intercalation. Biomacromolecules. 2012;13:873\u2013880. doi: 10.1021/bm2017959.", "ArticleIdList": ["10.1021/bm2017959", "22316074"]}, {"Citation": "Hu X., Wu X., Huang Y., Tong Q., Takeda S., Qing Y. Berberine induces double-strand DNA breaks in Rev3 deficient cells. Mol. Med. Rep. 2014;9:1883\u20131888. doi: 10.3892/mmr.2014.1999.", "ArticleIdList": ["10.3892/mmr.2014.1999", "24584584"]}, {"Citation": "Yuan Z.Y., Lu X., Lei F., Chai Y.S., Wang Y.G., Jiang J.F., Feng T.S., Wang X.P., Yu X., Yan X.J., et al. TATA boxes in gene transcription and poly (A) tails in mRNA stability: New perspective on the effects of berberine. Sci. Rep. 2015;5:18326. doi: 10.1038/srep18326.", "ArticleIdList": ["10.1038/srep18326", "PMC4680869", "26671652"]}, {"Citation": "Chai Y.S., Yuan Z.Y., Lei F., Wang Y.G., Hu J., Du F., Lu X., Jiang J.F., Xing D.M., Du L.J. Inhibition of retinoblastoma mRNA degradation through Poly (A) involved in the neuroprotective effect of berberine against cerebral ischemia. PLoS ONE. 2014;9:e90850. doi: 10.1371/journal.pone.0090850.", "ArticleIdList": ["10.1371/journal.pone.0090850", "PMC3946351", "24603897"]}, {"Citation": "Och A., Szewczyk K., Pecio \u0141., Stochmal A., Za\u0142uski D., Bogucka-Kocka A. UPLC-MS/MS Profile of Alkaloids with Cytotoxic Properties of Selected Medicinal Plants of the Berberidaceae and Papaveraceae Families. Oxid. Med. Cell. Longev. 2017;2017:9369872. doi: 10.1155/2017/9369872.", "ArticleIdList": ["10.1155/2017/9369872", "PMC5603144", "28951771"]}, {"Citation": "Aburai N., Yoshida M., Ohnishi M., Kimura K. Sanguinarine as a potent and specific inhibitor of protein phosphatase 2C in vitro and induces apoptosis via phosphorylation of p38 in HL60 cells. Biosci. Biotechnol. Biochem. 2010;74:548\u2013552. doi: 10.1271/bbb.90735.", "ArticleIdList": ["10.1271/bbb.90735", "20208361"]}, {"Citation": "Slaninov\u00e1 I., Slanina J., T\u00e1borsk\u00e1 E. Quaternary benzo[c]phenanthridine alkaloids\u2014Novel cell permeant and red fluorescing DNA probes. Cytometry A. 2007;71:700\u2013708. doi: 10.1002/cyto.a.20423.", "ArticleIdList": ["10.1002/cyto.a.20423", "17549765"]}, {"Citation": "Bogucka-Kocka A., Zalewski D. Qualitative and quantitative determination of main alkaloids of Chelidonium majus L. using thin-layer chromatographic-densitometric method. Acta Chromatogr. 2017;29:385\u2013397. doi: 10.1556/1326.2017.29.3.09.", "ArticleIdList": ["10.1556/1326.2017.29.3.09"]}, {"Citation": "Nadova S., Miadokova E., Alfoldiova L., Kopaskova M., Hasplova K., Hudecova A., Vaculcikova D., Gregan F., Cipak L. Potential antioxidant activity, cytotoxic and apoptosis-inducing effects of Chelidonium majus L. extract on leukemia cells. Neuro Endocrinol. Lett. 2008;29:649\u2013652.", "ArticleIdList": ["18987588"]}, {"Citation": "Zieli\u0144ska S., Jezierska-Domaradzka A., W\u00f3jciak-Kosior M., Sowa I., Junka A., Matkowski A.M. Greater Celandine\u2019s Ups and Downs-21 Centuries of Medicinal Uses of Chelidonium majus From the Viewpoint of Today\u2019s Pharmacology. Front. Pharmacol. 2018;9:299. doi: 10.3389/fphar.2018.00299.", "ArticleIdList": ["10.3389/fphar.2018.00299", "PMC5912214", "29713277"]}, {"Citation": "Hu H.Y., Li K.P., Wang X.J., Liu Y., Lu Z.G., Dong R.H., Guo H.B., Zhang M.X. Set9, NF-\u03baB, and \u00b5RNA-21 mediate berberine-induced apoptosis of human multiple myeloma cells. Acta Pharmacol. Sin. 2013;34:157\u2013166. doi: 10.1038/aps.2012.161.", "ArticleIdList": ["10.1038/aps.2012.161", "PMC4086496", "23247593"]}, {"Citation": "Efferth T., Davey M., Olbrich A., R\u00fccker G., Gebhart E., Davey R. Activity of drugs from traditional Chinese medicine toward sensitive and MDR1-or MRP1-overexpressing multidrug-resistant human CCRF-CEM leukemia cells. Blood Cells Mol. Dis. 2002;28:160\u2013168. doi: 10.1006/bcmd.2002.0492.", "ArticleIdList": ["10.1006/bcmd.2002.0492", "12064912"]}, {"Citation": "Bui N.L., Pandey V., Zhu T., Ma L., Basappa, Lobie P.E. BAD phosphorylation as a target of inhibition in oncology. Cancer Lett. 2018;415:177\u2013186. doi: 10.1016/j.canlet.2017.11.017.", "ArticleIdList": ["10.1016/j.canlet.2017.11.017", "29175460"]}, {"Citation": "Macher-Goeppinger S., Keith M., Hatiboglu G., Hohenfellner M., Schirmacher P., Roth W., Tagscherer K.E. Expression and Functional Characterization of the BNIP3 Protein in Renal Cell Carcinomas. Transl. Oncol. 2017;10:869\u2013875. doi: 10.1016/j.tranon.2017.08.008.", "ArticleIdList": ["10.1016/j.tranon.2017.08.008", "PMC5602480", "28918350"]}, {"Citation": "Singh A., Azad M., Shymko M.D., Henson E.S., Katyal S., Eisenstat D.D., Gibson S.B. The BH3 only Bcl-2 family member BNIP3 regulates cellular proliferation. PLoS ONE. 2018;13:e0204792. doi: 10.1371/journal.pone.0204792.", "ArticleIdList": ["10.1371/journal.pone.0204792", "PMC6181300", "30307949"]}, {"Citation": "Bishayee A., Rao D.V., Bouchet L.G., Bolch W.E., Howell R.W. Protection by DMSO against cell death caused by intracellularly localized iodine-125, iodine-131 and polonium-210. Radiat. Res. 2000;153:416\u2013427. doi: 10.1667/0033-7587(2000)153[0416:PBDACD]2.0.CO;2.", "ArticleIdList": ["10.1667/0033-7587(2000)153[0416:PBDACD]2.0.CO;2", "PMC3541040", "10761002"]}, {"Citation": "Chomczynski P., Sacchi N. The single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction: Twenty-something years on. Nat. Protoc. 2006;1:581\u2013585. doi: 10.1038/nprot.2006.83.", "ArticleIdList": ["10.1038/nprot.2006.83", "17406285"]}, {"Citation": "Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25:402\u2013408. doi: 10.1006/meth.2001.1262.", "ArticleIdList": ["10.1006/meth.2001.1262", "11846609"]}, {"Citation": "Schmittgen T.D., Livak K.J. Analyzing real-time PCR data by the comparative C (T) method. Nat. Protoc. 2008;3:1101\u20131108. doi: 10.1038/nprot.2008.73.", "ArticleIdList": ["10.1038/nprot.2008.73", "18546601"]}]}], "History": [{"Year": "2019", "Month": "7", "Day": "31"}, {"Year": "2019", "Month": "8", "Day": "20"}, {"Year": "2019", "Month": "8", "Day": "21"}, {"Year": "2019", "Month": "8", "Day": "25", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "8", "Day": "25", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "10", "Day": "21", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "9", "Day": "1"}], "PublicationStatus": "epublish", "ArticleIdList": ["31443589", "PMC6784183", "10.3390/toxins11090485", "toxins11090485"]}}]}